PRESTRELSKI STEVEN (Chief Scientific Officer) received a stock award from XERIS PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/1/2021ACC: 0001346302-21-000012
Officer· Chief Scientific Officer
Since Dec 2018
+100K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
100K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+100K
Price / share
—
Trade value
—
% of position
24.6%
1/29/2021
406.82K→506.82K
Total
Net shares
+100K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/29/2021 | A · Award | +100K | — | — | 24.6% | 406.82K | 506.82K |
| Total | +100K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported